Tests new immune tests for tuberculosis in children in Switzerland
Checks new immune tests for tuberculosis infection and disease in children.
Plain-language title generated from the registry record
Registry title: Diagnosis of Tuberculosis in Swiss Children
Key facts
- Where
- Aarau, Basel, Bellinzona, Bern, Geneva, Lucerne, Sankt Gallen, and Zurich, SwitzerlandSee the 8 sites
Where in Switzerland
- Kantonspital AarauAarau, SwitzerlandTaking people
- Nina VaezipourBasel, SwitzerlandTaking people
- Ospedale Regionale Di BellinzonaBellinzona, SwitzerlandTaking people
- Inselspital BernBern, SwitzerlandTaking people
- Hopital des Enfants HUGGeneva, SwitzerlandTaking people
- Kinserspital LuzernLucerne, SwitzerlandTaking people
- Kinderspital St GallenSankt Gallen, SwitzerlandTaking people
- Kinderklinik ZürichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Children's Hospital Basel
- Trial code
- NCT03044509
- Record updated
- 19 September 2024
- Original description
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.Read full original descriptionShow less
Evaluation and Validation of Novel Immunodiagnostic Tests for Childhood Tuberculosis Infection and Disease in Switzerland. The CITRUS (ChIldhood TubeRcUlosis in Switzerland) Study.
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.
Inclusion: all children / adolescents < 18 years of age undergoing evaluation for TB exposure, infection or disease.
Exclusion: children / adolescents with TB infection or disease who have already been started on anti-mycobacterial treatment, children who have been treated for TB previously.